These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 30740661)

  • 1. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
    Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
    Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of microglia in Alzheimer's disease: a new dog in the fight.
    Moore Z; Taylor JM; Crack PJ
    Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
    Duce JA; Zhu X; Jacobson LH; Beart PM
    Br J Pharmacol; 2019 Sep; 176(18):3409-3412. PubMed ID: 31468515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 and the neuroimmunology of Alzheimer's disease.
    Hickman SE; El Khoury J
    Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Active Ingredients Targeted TREM2 by SPR Biosensor-UPLC/MS Recognition System, and Investigating the Mechanism of Anti-Neuroinflammatory Activity on the Lignin-Amides from
    Wang SY; Liu Y; Li XM; Algradi AM; Jiang H; Sun YP; Guan W; Pan J; Kuang HX; Yang BY
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease.
    Lewcock JW; Schlepckow K; Di Paolo G; Tahirovic S; Monroe KM; Haass C
    Neuron; 2020 Dec; 108(5):801-821. PubMed ID: 33096024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
    Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2, microglia, and Alzheimer's disease.
    Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
    Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
    Ittner LM; Klugmann M; Ke YD
    Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.
    Terzioglu G; Young-Pearse TL
    Mol Neurodegener; 2023 Nov; 18(1):89. PubMed ID: 38017562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
    Qu W; Li L
    Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease.
    Li Y; Xu H; Wang H; Yang K; Luan J; Wang S
    Biomed Pharmacother; 2023 Sep; 165():115218. PubMed ID: 37517293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
    García-Culebras A; Cuartero MI; Peña-Martínez C; Moraga A; Vázquez-Reyes S; de Castro-Millán FJ; Cortes-Canteli M; Lizasoain I; Moro MÁ
    Br J Pharmacol; 2024 Mar; 181(6):777-798. PubMed ID: 37282844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Alzheimer's disease by targeting iron.
    Nikseresht S; Bush AI; Ayton S
    Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.
    Herman FJ; Simkovic S; Pasinetti GM
    Br J Pharmacol; 2019 Sep; 176(18):3558-3584. PubMed ID: 30632147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.